Trademarkia Logo

Australia

AU$
TIFORBEX
Cancelled: Cancelled at the request of IB

Last updated on 27 Nov 2014

Owner Info

Iroko Pharmaceuticals LLC

The Navy Yard Corporate Center,

One Crescent Drive, Suite 400, UNITED STATES OF AMERICA

Serial Number

1453417 filed on 7 Sept 2011

Correspondent

Keith Barritt Fish & Richardson P.C.

P.O. Box 1022,

Minneapolis, MN 55440-1022,

UNITED STATES OF AMERICA

TIFORBEX

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of pain and pain associated with inflammation

Mark Details


Serial Number

1453417

Registered On

7 Sept 2011

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

1 Sept 2011

Mark Type

US

Legal History


Show more

Status DateAction Taken
27th Nov 2014Cancellation of Entry in Register Published
20th Nov 2014Cancel IP Right
11th Sept 2014General Correspondence (Application or Registration)
14th Jul 2014Amendment to Application/Registration
5th Apr 2012IP Right Registration Published
30th Mar 2012Register Trade Mark
30th Mar 2012Application Status
22nd Dec 2011IP Right Acceptance Published
15th Dec 2011Amend Status from Awaiting Advertisement
29th Oct 2011Clear Examination report approved